GRTX logo

Galera Therapeutics (GRTX) Cash From Financing

Annual CFF

$31.50 M
+$27.61 M+709.87%

December 31, 2023


Summary


Performance

GRTX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGRTXcash flowmetrics:

Quarterly CFF

$0.00
$0.000.00%

September 1, 2024


Summary


Performance

GRTX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGRTXcash flowmetrics:

TTM CFF

-$232.00 K
-$2.13 M-112.20%

September 1, 2024


Summary


Performance

GRTX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGRTXcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

GRTX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+709.9%+100.0%-100.7%
3 y3 years+53.6%+100.0%-100.7%
5 y5 years-64.9%+100.0%-100.7%

GRTX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-52.8%+709.9%-100.0%+100.0%-100.3%at low
5 y5-year-59.6%+709.9%-100.0%+100.0%-100.2%at low
alltimeall time-64.9%-100.0%-100.0%+100.0%-100.2%at low

Galera Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
-$232.00 K(-112.2%)
Jun 2024
-
$0.00(0.0%)
$1.90 M(-48.8%)
Mar 2024
-
$0.00(-100.0%)
$3.71 M(-88.2%)
Dec 2023
$31.50 M(+709.9%)
-$232.00 K(-110.9%)
$31.50 M(-8.5%)
Sep 2023
-
$2.13 M(+17.8%)
$34.43 M(+6.6%)
Jun 2023
-
$1.81 M(-93.5%)
$32.31 M(+5.9%)
Mar 2023
-
$27.78 M(+928.2%)
$30.50 M(+684.2%)
Dec 2022
$3.89 M(-94.2%)
$2.70 M(>+9900.0%)
$3.89 M(+221.7%)
Sep 2022
-
$10.00 K(+400.0%)
$1.21 M(-97.1%)
Jun 2022
-
$2000.00(-99.8%)
$41.81 M(-38.2%)
Mar 2022
-
$1.18 M(+5240.9%)
$67.65 M(+1.4%)
Dec 2021
$66.71 M
$22.00 K(-99.9%)
$66.71 M(-0.3%)
DateAnnualQuarterlyTTM
Sep 2021
-
$40.61 M(+57.2%)
$66.92 M(+152.2%)
Jun 2021
-
$25.84 M(>+9900.0%)
$26.53 M(+3524.2%)
Mar 2021
-
$235.00 K(+1.3%)
$732.00 K(-96.4%)
Dec 2020
$20.51 M(-73.7%)
$232.00 K(+3.6%)
$20.51 M(-74.4%)
Sep 2020
-
$224.00 K(+446.3%)
$79.98 M(+0.7%)
Jun 2020
-
$41.00 K(-99.8%)
$79.41 M(-19.0%)
Mar 2020
-
$20.01 M(-66.5%)
$98.04 M(+25.6%)
Dec 2019
$78.03 M(-13.1%)
$59.70 M(<-9900.0%)
$78.03 M(+325.7%)
Sep 2019
-
-$345.00 K(-101.8%)
$18.33 M(-1.8%)
Jun 2019
-
$18.67 M(>+9900.0%)
$18.67 M(>+9900.0%)
Mar 2019
-
$0.00
$0.00
Dec 2018
$89.84 M(>+9900.0%)
-
-
Dec 2017
$0.00
-
-

FAQ

  • What is Galera Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Galera Therapeutics?
  • What is Galera Therapeutics annual CFF year-on-year change?
  • What is Galera Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Galera Therapeutics?
  • What is Galera Therapeutics quarterly CFF year-on-year change?
  • What is Galera Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Galera Therapeutics?
  • What is Galera Therapeutics TTM CFF year-on-year change?

What is Galera Therapeutics annual cash flow from financing activities?

The current annual CFF of GRTX is $31.50 M

What is the all time high annual CFF for Galera Therapeutics?

Galera Therapeutics all-time high annual cash flow from financing activities is $89.84 M

What is Galera Therapeutics annual CFF year-on-year change?

Over the past year, GRTX annual cash flow from financing activities has changed by +$27.61 M (+709.87%)

What is Galera Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of GRTX is $0.00

What is the all time high quarterly CFF for Galera Therapeutics?

Galera Therapeutics all-time high quarterly cash flow from financing activities is $59.70 M

What is Galera Therapeutics quarterly CFF year-on-year change?

Over the past year, GRTX quarterly cash flow from financing activities has changed by +$232.00 K (+100.00%)

What is Galera Therapeutics TTM cash flow from financing activities?

The current TTM CFF of GRTX is -$232.00 K

What is the all time high TTM CFF for Galera Therapeutics?

Galera Therapeutics all-time high TTM cash flow from financing activities is $98.04 M

What is Galera Therapeutics TTM CFF year-on-year change?

Over the past year, GRTX TTM cash flow from financing activities has changed by -$31.73 M (-100.74%)